ISPE‐Endorsed Guidance in Using Electronic Health Records for Comparative Effectiveness Research in COVID‐19: Opportunities and Trade‐Offs
Sarri G, Bennett D, Debray T, Deruaz‐Luyet A, Gabarró M, Largent JA, Li X, Liu W, Lund JL, Moga DC, Gokhale M, Rentsch CT, Wen X, Yanover C, Ye Y, Yun H, Zullo AR, Lin KJ. ISPE‐Endorsed Guidance in Using Electronic Health Records for Comparative Effectiveness Research in COVID‐19: Opportunities and Trade‐Offs. Clinical Pharmacology & Therapeutics 2022, 112: 990-999. PMID: 35170021, PMCID: PMC9087010, DOI: 10.1002/cpt.2560.Peer-Reviewed Original ResearchConceptsComparative effectiveness researchElectronic health recordsRoutine careCOVID-19Health recordsCoronavirus disease 2019 (COVID-19) pandemicLong-term treatment effectsEHR dataEffectiveness researchDisease 2019 pandemicRigorous study designsCOVID-19-related questionsAscertainment of outcomesVaccine effectivenessComplex patientsExposure statusHealthcare databasesTherapeutic interventionsOptimal managementHealthcare professionalsClinical researchStudy designTreatment effectsAppropriate statistical methodsInternational Society